For over half a century, Kyowa Hakko has been a world leader in the development, manufacturing and marketing of pharmaceuticals, bio-products, chemicals, food, agrochemical, and animal health products.

A pioneer in the development and application of fermentation technology, Kyowa has achieved its leadership position through a constant commitment to research, innovative products, and total quality management. Drawing on these core abilities, and guided by its corporate mission to improve people's health and well-being, Kyowa today operates in more than 80 countries, through over 50 corporate facilities, subsidiaries, and affiliates around the globe.

To better serve rapidly evolving worldwide markets, the Company is aggressively expanding its capabilities and establishing new global centers for pharmaceutical R & D, manufacturing, and marketing. In the Americas, Kyowa Pharmaceuticals, Inc. (KPI) is at the focal point of efforts aimed at the clinical development of priority drugs, including anti-cancer and anti-Parkinson's disease agents.

Kyowa Hakko U.S.A., Inc. provides pharmaceutical specialties, fine and industrial chemicals, nutritional supplements and food-related products to a broad range of markets and industries. The following represents a sampling of our primary business categories and products